Health TrialsbyHealthPanel

Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

2

Review clinical trials related to Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38.

This is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of GNTbm-38 in adult patients with advanced solid tumors and R/R PTCL.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Great Novel Therapeutics Biotech & Medicals CorporationUpdated: Sep 25, 2026
Eligibility criteria

Female and/or male aged ≥ 18 to ≤ 75 years. [+24]

Underlying physical or psychological medical condition that, in the opinion of t... [+8]

Read more
Status: Recruiting

A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

This is a multicentre, open-label phase Ib/II study. The purpose of the study is to assess the efficacy, safety/ tolerability and pharmacokinetic of GFH009 monotherapy in patients with relapsed or refractory peripheral T-cell lymphoma

Participants needed: 95
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Genfleet Therapeutics (Shanghai) Inc.Updated: Dec 13, 2024Locations: 1
Eligibility criteria

Male or female ≥ 18 years and ≤ 75 years. [+10]

Diagnosis of Cutaneous T-cell lymphoma . [+17]

Read more